Molecular relapse after first-line intensive therapy in patients with CBF or NPM1-mutated acute myeloid leukemia - a FILO study.

Different OS rates, that did not reach statistical significance, were observed between the three treatment strategies (92% vs . 79% vs . 58% at three years for upfront allogeneic HCT, intensive chemotherapy, and less intensive therapy, respectively, P = 0.09; Fig. 4 ).

also in 111,027 other papers